Aprepitant for the prevention of chemotherapy-induced nausea and vomiting

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
To compare the antiemetic combination of palonosetron, dexamethasone, and aprepitant (PDA) with antiemetic combination of palonosetron and dexamethasone (PD) in nasopharyngeal carcinoma patients receiving docetaxel, cisplatin, and 5-FU based chemotherapy.
Epistemonikos ID: adde0ad57b9177c12b7c0e782d95c7387f497da6
First added on: May 17, 2024